Suitable reports have not been executed on the relationship of age to the consequences of amphetamine prolonged-launch oral suspension, prolonged-launch tablets, Adzenys XR-ODT® extended-release oral disintegrating tablets, and Evekeo ODT® prolonged-release oral disintegrating tablets in young children with ADHD that are young than 6 several year